cd138 antibody, anti-human, reafinity (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
93
Structured Review
Miltenyi Biotec
cd138 antibody, anti-human, reafinity
Cd138 Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd138/CD138+Antibody%2C+anti-human%2C+REAfinity/custom%40130-115-478%4042502392
Average 93 stars, based on 10 article reviews
Cd138 Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd138/CD138+Antibody%2C+anti-human%2C+REAfinity/custom%40130-115-478%4042502392
Average 93 stars, based on 10 article reviews
cd138 antibody, anti-human, reafinity - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Staining:Article Title: Systemic deficits in lipid homeostasis promote aging-associated impairments in B cell progenitor development Article Snippet: .. Cells underwent viability stain and cell-surface staining against CD19 (viobright 515, (Miltenyi, # 130–112-040)), Article Title: Systemic deficits in lipid homeostasis promote aging-associated impairments in B cell progenitor development. Article Snippet: .. Plasma cell panel with fixation: Cells underwent viability stain and cell-surface staining against CD19 (viobright 515, (Miltenyi, # 130–112-040)), Isolation:Article Title: Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma Article Snippet: Bone marrow mononuclear cells (BMMCs) were isolated using Ficoll-Paque (Cytiva, Marlborough, MA) according to the manufacturer’s protocol. .. Article Title: Targeting the HuR/E2F7 axis synergizes with bortezomib against multiple myeloma. Article Snippet: Patient samples Density gradient centrifugation with Ficoll-Paque Plus (Sigma‒ Aldrich, St. Louis, MO) was used to isolate BMMCs from MM patients and PBMCs from healthy donors. .. Article Title: PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism. Article Snippet: .. To separate the Article Title: Targeting the HuR/E2F7 axis synergizes with bortezomib against multiple myeloma Article Snippet: Density gradient centrifugation with Ficoll-Paque Plus (Sigma‒Aldrich, St. Louis, MO) was used to isolate BMMCs from MM patients and PBMCs from healthy donors. .. Magnetic Cell Separation:Article Title: Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma Article Snippet: Bone marrow mononuclear cells (BMMCs) were isolated using Ficoll-Paque (Cytiva, Marlborough, MA) according to the manufacturer’s protocol. .. Clinical Proteomics:Article Title: Targeting the HuR/E2F7 axis synergizes with bortezomib against multiple myeloma. Article Snippet: Patient samples Density gradient centrifugation with Ficoll-Paque Plus (Sigma‒ Aldrich, St. Louis, MO) was used to isolate BMMCs from MM patients and PBMCs from healthy donors. .. Article Title: Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteins. Article Snippet: For producing i35 Bregs used for treatment of GVHD mice, CD19+ B cells were isolated from the spleen of donor B6C3F1/Cr1 mice using CD19 specific magnetic microbeads (Miltenyi Biotec, San Diego, CA). .. The CD19+B220+ cells were seeded at a density of 2×106 cells/mL, stimulated with LPS (5 μg/mL) or anti-IgM (5 μg/mL) with anti-CD40 (5 μg/mL) and rIL-35 (50 ng/mL) at a concentration of 2×106 cells/mL for 72 h. The cells were enriched for Article Title: Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteins Article Snippet: For producing i35 Bregs used for treatment of GVHD mice, CD19 + B cells were isolated from the spleen of donor B6C3F1/Cr1 mice using CD19 specific magnetic microbeads (Miltenyi Biotec, San Diego, CA). .. The CD19 + B220 + cells were seeded at a density of 2×10 6 cells/mL, stimulated with LPS (5 μg/mL) or anti-IgM (5 μg/mL) with anti-CD40 (5 μg/mL) and rIL-35 (50 ng/mL) at a concentration of 2×10 6 cells/mL for 72 h. The cells were enriched for Article Title: Targeting the HuR/E2F7 axis synergizes with bortezomib against multiple myeloma Article Snippet: Density gradient centrifugation with Ficoll-Paque Plus (Sigma‒Aldrich, St. Louis, MO) was used to isolate BMMCs from MM patients and PBMCs from healthy donors. .. Article Title: Systemic deficits in lipid homeostasis promote aging-associated impairments in B cell progenitor development. Article Snippet: .. Plasma cell panel with fixation: Cells underwent viability stain and cell-surface staining against CD19 (viobright 515, (Miltenyi, # 130–112-040)), Concentration Assay:Article Title: Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteins. Article Snippet: For producing i35 Bregs used for treatment of GVHD mice, CD19+ B cells were isolated from the spleen of donor B6C3F1/Cr1 mice using CD19 specific magnetic microbeads (Miltenyi Biotec, San Diego, CA). .. The CD19+B220+ cells were seeded at a density of 2×106 cells/mL, stimulated with LPS (5 μg/mL) or anti-IgM (5 μg/mL) with anti-CD40 (5 μg/mL) and rIL-35 (50 ng/mL) at a concentration of 2×106 cells/mL for 72 h. The cells were enriched for Article Title: Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteins Article Snippet: For producing i35 Bregs used for treatment of GVHD mice, CD19 + B cells were isolated from the spleen of donor B6C3F1/Cr1 mice using CD19 specific magnetic microbeads (Miltenyi Biotec, San Diego, CA). .. The CD19 + B220 + cells were seeded at a density of 2×10 6 cells/mL, stimulated with LPS (5 μg/mL) or anti-IgM (5 μg/mL) with anti-CD40 (5 μg/mL) and rIL-35 (50 ng/mL) at a concentration of 2×10 6 cells/mL for 72 h. The cells were enriched for FACS:Article Title: Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteins. Article Snippet: For producing i35 Bregs used for treatment of GVHD mice, CD19+ B cells were isolated from the spleen of donor B6C3F1/Cr1 mice using CD19 specific magnetic microbeads (Miltenyi Biotec, San Diego, CA). .. The CD19+B220+ cells were seeded at a density of 2×106 cells/mL, stimulated with LPS (5 μg/mL) or anti-IgM (5 μg/mL) with anti-CD40 (5 μg/mL) and rIL-35 (50 ng/mL) at a concentration of 2×106 cells/mL for 72 h. The cells were enriched for Article Title: Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteins Article Snippet: For producing i35 Bregs used for treatment of GVHD mice, CD19 + B cells were isolated from the spleen of donor B6C3F1/Cr1 mice using CD19 specific magnetic microbeads (Miltenyi Biotec, San Diego, CA). .. The CD19 + B220 + cells were seeded at a density of 2×10 6 cells/mL, stimulated with LPS (5 μg/mL) or anti-IgM (5 μg/mL) with anti-CD40 (5 μg/mL) and rIL-35 (50 ng/mL) at a concentration of 2×10 6 cells/mL for 72 h. The cells were enriched for Article Title: PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism. Article Snippet: .. To separate the Cell Isolation:Article Title: Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteins. Article Snippet: For producing i35 Bregs used for treatment of GVHD mice, CD19+ B cells were isolated from the spleen of donor B6C3F1/Cr1 mice using CD19 specific magnetic microbeads (Miltenyi Biotec, San Diego, CA). .. The CD19+B220+ cells were seeded at a density of 2×106 cells/mL, stimulated with LPS (5 μg/mL) or anti-IgM (5 μg/mL) with anti-CD40 (5 μg/mL) and rIL-35 (50 ng/mL) at a concentration of 2×106 cells/mL for 72 h. The cells were enriched for Article Title: Interleukin 35-producing B cells prolong the survival of GVHD mice by secreting exosomes with membrane-bound IL-35 and upregulating PD-1/LAG-3 checkpoint proteins Article Snippet: For producing i35 Bregs used for treatment of GVHD mice, CD19 + B cells were isolated from the spleen of donor B6C3F1/Cr1 mice using CD19 specific magnetic microbeads (Miltenyi Biotec, San Diego, CA). .. The CD19 + B220 + cells were seeded at a density of 2×10 6 cells/mL, stimulated with LPS (5 μg/mL) or anti-IgM (5 μg/mL) with anti-CD40 (5 μg/mL) and rIL-35 (50 ng/mL) at a concentration of 2×10 6 cells/mL for 72 h. The cells were enriched for |